Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against LeishmaniaDevki Nandan(Indian Institute of Technology Kanpur), Neil E. Reiner(University of British Columbia)PLoS ONENovember 6, 201810.1371/journal.pone.0206920Cited by 24SaveCiteExport RISWatch citationsRelated PapersClass IA Phosphatidylinositol 3-Kinase p110α Regulates Phagosome Maturation|PLoS ONE|2012|9